Schedule 13D ownership disclosure

VIVOS THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 92859E207

Event date: 2025-06-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • V-CO Investors LLCReported CIK 0002049575

    Shares: 514,498.00 · Class: 7.7%

  • V-Co Investors 2 LLC

    Shares: 828,000.00 · Class: 12.3%

  • SP Manager LLC

    Shares: 1,342,498.00 · Class: 19.9%

  • Michael C. Skaff

    Shares: 1,342,498.00 · Class: 19.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002049575-25-000002
Form type
SCHEDULE 13D
Filer
V-CO Investors LLC
CIK
CIK 2049575
Filed
Jun 16, 2025
Reporting period
Jun 09, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub